발행물
컨퍼런스
Slective Inhibition of HDAC6 regulates preferential cytotoxicity in cancer cells by modulating the acetylation and stability of p53 and Hsp90
2016
,
2016 International Conference of the Korean Society for Molecular and Cellular Biology
The selective inhibitor of HDAC6 synergistically enhances the anticancer activity of immunomodulatory drugs in multiple myeloma
Tenth AACR-JCA Joint Conference on Breakthroughs in Cancer Research
Selective Inhibition of HDAC6 regulates preferential cytotoxicity in cancer cells by modulating the deacetylation and stability
2015
2015년 KSMCB 에피유전체학분과 심포지엄
Selective inhibition of KDM4 induces apoptosis and sensitizes glioblastoma cells to anticancer agents
ACT2015
Selective Inhibition of HDAC6 regulates preferential cytotoxicity in cancer cells by modulating p53 and Hsp90 stability
2015 생화학분자생물학회 (KSBMB international conference 2015)